Sign up for free insights newsletter
Cencora Inc.

Cencora Inc.

CORUnited States

Need professional-grade analysis? Visit stockanalysis.com

$327.27
+0.11%
End of day
Market Cap

$68.08B

P/E Ratio

42.01

Employees

47,000

Dividend Yield

0.64%

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino-0.540.791.170.62
Calmar-1.191.311.730.86
Sharpe-0.430.610.880.46
Omega0.921.161.201.11
Martin-4.673.104.801.87
Ulcer3.255.584.774.66

Cencora Inc. (COR) Price Performance

Cencora Inc. (COR) trades on United States in USD. The company is classified in the Healthcare sector under the Medical Distribution industry. The stock currently trades at $327.27, up 0.11% from the previous close.

Over the past year, COR has traded between a low of $269.92 and a high of $374.75. The stock has gained 21.2% over this period. It is currently 12.7% below its 52-week high.

Cencora Inc. has a market capitalization of $68.08B, with a price-to-earnings ratio of 42.01 and a dividend yield of 0.64%.

About Cencora Inc.

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.

Company Info

Exchange
United States
Currency
USD

Financial Metrics

Revenue (TTM)
$262.17B
EBITDA
$4.96B
Profit Margin
0.50%
EPS (TTM)
8.75
Book Value
9.81

Technical Indicators

52 Week High
$377.54
52 Week Low
$265.95
50 Day MA
$354.85
200 Day MA
$323.86
Beta
0.65

Valuation

Trailing P/E
42.01
Forward P/E
19.84
Price/Sales
0.21
Price/Book
35.67
Enterprise Value
$71.38B